Gland Pharma posts Q4 FY23 consolidated PAT at Rs. 78.68 Cr
News

Gland Pharma posts Q4 FY23 consolidated PAT at Rs. 78.68 Cr

Gland Pharma has reported total income of Rs. 823.95 crores during the period ended March 31, 2023

  • By IPP Bureau | May 19, 2023

Gland Pharma Limited has posted net profit of Rs. 78.68 crores for the period ended March 31, 2023 as against net profit of Rs. 231.94 crores for the period ended December 31, 2022. The company posted net profit of Rs.285.90 crores for the period ended March 31, 2022.

Gland Pharma has reported total income of Rs. 823.95 crores during the period ended March 31, 2023 as compared to Rs. 999.79 crores during the period ended December 31, 2022. The company reported total income of Rs.1168.24 crores during the period ended March 31, 2022.

For the Finnacial Year ended March 31, 2023, Gland Pharma has reported total income of Rs.3865.06 crores  as compared to Rs.4624.64 crores during the Financial Year ended March 31, 2022.

The company has posted net profit of Rs.781.04 crores for the Financial Year ended March 31, 2023 as against net profit of Rs.1211.66 crores for the Financial Year ended March 31, 2022.

 

Upcoming E-conference

Other Related stories

Startup

Digitization